3,4-Dimethylmethcathinone
| |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C12H17NO |
Molar mass | 191.269 g/mol |
3D model (JSmol) | |
| |
| |
|
3,4-Dimethylmethcathinone (3,4-DMMC) is a stimulant drug first reported in 2010 as a designer drug analogue of mephedrone, apparently produced in response to the banning of mephedrone, following its widespread abuse in many countries in Europe and around the world.[1] 3,4-DMMC has been seized as a designer drug in Australia.[2]
Legal Status
As of October 2015 3,4-DMMC is a controlled substance in China.[3]
3,4-DMMC is banned in the Czech Republic.[4]
See also
References
- ↑ EMCDDA Annual Report 2010
- ↑ Locos, O.; Reynolds, D. (2012). "The Characterization of 3,4-Dimethylmethcathinone (3,4-DMMC)". Journal of Forensic Sciences. 57 (5): 1303–1306. doi:10.1111/j.1556-4029.2012.02142.x. PMID 22564211.
- ↑ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
- ↑ "Látky, o které byl doplněn seznam č. 4 psychotropních látek (příloha č. 4 k nařízení vlády č. 463/2013 Sb.)" (PDF) (in Czech). Ministerstvo zdravotnictví.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.